On October 20, 2025, scientists announced a significant advancement toward curing HIV, marking a pivotal moment in the ...
Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie recently updated its clinical study titled A ...
The drug, Lenacapavir, is the world's first injectable Pre-Exposure Prophylaxis (PrEP). According to the World Health ...
Dr Joel Steingo of TB HIV Care says Lenacapavir could be a breakthrough in reducing infections, especially at a time when ...
The timing of the renewed support is pivotal. South Africa is preparing to roll out Lenacapavir, a groundbreaking long-acting ...
The United Nations agency focusing on the HIV/AIDS pandemic could close by the end of next year as the U.N. restructures in ...
The interdisciplinary research team at the School of Medicine will work together to explore the effects of factors like ...